Donna M Peehl

Title: The Innovative Contributions of Donna M Peehl

Introduction

Donna M Peehl is a prominent inventor based in Mountain View, CA (US). She has made significant strides in the field of cancer research, particularly focusing on prostate cancer. Her work has led to the development of innovative methods for detecting glycan markers and autoantibody signatures associated with prostate cancer.

Latest Patents

Donna M Peehl holds 1 patent for her invention titled "Prostate cancer glycan markers and autoantibody signatures." This patent discloses methods for probing the immunogenic sugar moieties of prostate cancer cells. The methods are designed to detect various glyco-epitopes that are highly and differentially expressed among prostate cancers of different Gleason grades. These glyco-epitopes are found on the surfaces of prostate cells. Additionally, the methods include the detection of autoantibodies in prostate cancer subjects, targeting a glyco-motif of N-glycans that is typically 'cryptic' but highly expressed in prostate cancers. The patent also mentions several lectins and antibodies that can detect these glyco-epitopes in prostate cancer tissues.

Career Highlights

Donna M Peehl is affiliated with Leland Stanford Junior University, where she continues her research and innovation in cancer diagnostics. Her work has contributed to a better understanding of prostate cancer and has the potential to improve diagnostic methods for this disease.

Collaborations

Throughout her career, Donna has collaborated with notable colleagues, including Leonore A Herzenberg and Leonard A Herzenberg. These collaborations have further enriched her research and have led to advancements in the field of cancer diagnostics.

Conclusion

Donna M Peehl's contributions to the field of prostate cancer research exemplify the impact of innovative thinking in medical science. Her patented methods for detecting glycan markers and autoantibody signatures represent a significant advancement in cancer diagnostics.